Oxford Immunotec Global reported $275K in Operating Profit for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Bruker BRKR:US $ 113.2M 27.6M
Computer Programs Systems CPSI:US $ 4.53M 3.21M
Cytori Therapeutics CYTX:US $ -3499000 924K
Edap Tms EDAP:US $ -1.88M 1.46M
Fluidigm FLDM:US -19612000 2.34M
Genmark Diagnostics GNMK:US $ -2.09M 0.82M
Hologic HOLX:US $ 439.5M 80.9M
Illumina ILMN:US $ -545000000 732M
Laboratory Of America LH:US $ 766.9M 67.8M
Luminex LMNX:US $ 13.46M 2.96M
Myriad Genetics MYGN:US $ -79.9M 59.1M
Natus Medical BABY:US $ 8.54M 2.53M
Oxford Immunotec Global OXFD:US $ 0.28M 10.11M
Pacific Biosciences Of California PACB:US $ -74.48M 36.9M
Quest Diagnostics DGX:US $ 652M 119M
Quidel QDEL:US $ 281.84M 258.54M
Sientra SIEN:US -11694000 2.54M
Thermo Fisher Scientific TMO:US $ 2278M 115M
Trinity Biotech TRIB:US $ 0.22M 2.86M
Veracyte VCYT:US $ -16.68M 9.21M
Waters WAT:US $ 191.82M 4.61M